Pharma Sources Insight June 2022: New Developments of COVID-19, Greater Impact on the Pharma Market

How to Subscribe?

About Pharma Sources Insight

Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with those among the leading drug-manufacturers in China which further affect the world. 

Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and medical suppliers to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPhI China.

Pharma Sources Insight June 2022 focuses on the following topics and more:

Brand Story

- International Perspective, Cutting-edge Technology Learning, Entering into Hongke Technology Co., Ltd.

Fighting Against COVID-19

- Outlook for Covid-19 in 2022 H2 and Its Broader Impact on the Pharma Market

- With First Chinese Small-molecule Oral Drug for COVID-19 Coming,  What New Opportunities are Ushered in by the Relevant Industry Chain

- Is mRNA Vaccine the Source of Intricacies of "Mysterious Hepatitis"?

GLOBAL Market Review

- First Drug Coming Soon as Pharmaceutical Companies Take Actions in the B7-H3 Immune Target Products Layout

- Antibody-Drug Conjugates - Lessons Learned

PHARMA IN CHINA

- Popular Products and Companies at PharmaSources

- Chinese Pharmaceutical Companies Entering the DC Vaccine Market Under the Support of Tens of Millions of Financing

- IPOs Review of Chinese Biomedical Companies in 2021

INDUSTRY INSIGHT

- Standard for Integrity Testing

- 3D Printing, A Perfect Storm for Pharma Industry and Regulatory Agency

How to read the full issue?

1. Register or Log in and click Download PSI for Free below.

2. Register or Log in to show the password, copy the password and unlock the full issue.